rs16983466
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_016335.6(PRODH):c.1278C>T(p.Asp426=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.19 ( 83 hom., cov: 2)
Exomes 𝑓: 0.22 ( 6255 hom. )
Consequence
PRODH
NM_016335.6 synonymous
NM_016335.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.632
Genes affected
PRODH (HGNC:9453): (proline dehydrogenase 1) This gene encodes a mitochondrial protein that catalyzes the first step in proline degradation. Mutations in this gene are associated with hyperprolinemia type 1 and susceptibility to schizophrenia 4 (SCZD4). This gene is located on chromosome 22q11.21, a region which has also been associated with the contiguous gene deletion syndromes, DiGeorge and CATCH22. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 22-18918465-G-A is Benign according to our data. Variant chr22-18918465-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 1166601.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-18918465-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.632 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.226 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRODH | NM_016335.6 | c.1278C>T | p.Asp426= | synonymous_variant | 11/14 | ENST00000357068.11 | NP_057419.5 | |
PRODH | NM_001195226.2 | c.954C>T | p.Asp318= | synonymous_variant | 11/14 | NP_001182155.2 | ||
PRODH | NM_001368250.2 | c.954C>T | p.Asp318= | synonymous_variant | 11/14 | NP_001355179.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRODH | ENST00000357068.11 | c.1278C>T | p.Asp426= | synonymous_variant | 11/14 | 1 | NM_016335.6 | ENSP00000349577 | P3 |
Frequencies
GnomAD3 genomes AF: 0.189 AC: 581AN: 3082Hom.: 83 Cov.: 2
GnomAD3 genomes
AF:
AC:
581
AN:
3082
Hom.:
Cov.:
2
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.144 AC: 35182AN: 244830Hom.: 2689 AF XY: 0.141 AC XY: 18733AN XY: 132756
GnomAD3 exomes
AF:
AC:
35182
AN:
244830
Hom.:
AF XY:
AC XY:
18733
AN XY:
132756
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.218 AC: 33724AN: 154810Hom.: 6255 Cov.: 0 AF XY: 0.212 AC XY: 17516AN XY: 82624
GnomAD4 exome
AF:
AC:
33724
AN:
154810
Hom.:
Cov.:
0
AF XY:
AC XY:
17516
AN XY:
82624
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.189 AC: 583AN: 3092Hom.: 83 Cov.: 2 AF XY: 0.188 AC XY: 272AN XY: 1446
GnomAD4 genome
AF:
AC:
583
AN:
3092
Hom.:
Cov.:
2
AF XY:
AC XY:
272
AN XY:
1446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
384
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Proline dehydrogenase deficiency;C1833247:Schizophrenia 4 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 22, 2021 | - - |
Proline dehydrogenase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at